Title: Evaluation of patients treated with direct-acting anti-viral therapy for chronic hepatitis C
and their risk of hepatocellular carcinoma in Hong Kong
Version: 3 Date: 11 Nov 2023
Reviewer's report:
1. In the abstract,  The conclusion should be revised. This article not just discussed  the recurrence
of HCC, but also the HCC incidence.
2. The introduction should be concise and clear.
3. Figure 5-7 should be merged into 1 figure.
4. And due to the limited data, the conclusion should made carefully.
Title: Evaluation of patients treated with direct-acting anti-viral therapy for chronic hepatitis C
and their risk of hepatocellular carcinoma in Hong Kong
Version: 3 Date: 11 Nov 2023
Reviewer's report:
1. In the abstract,  The conclusion should be revised. This article not just discussed  the recurrence
of HCC, but also the HCC incidence.
2. The introduction should be concise and clear.
3. Figure 5-7 should be merged into 1 figure.
4. And due to the limited data, the conclusion should made carefully.
Please review this paper.
user
Title: Evaluation of patients treated with direct-acting anti-viral therapy for chronic hepatitis C
and their risk of hepatocellular carcinoma in Hong Kong
Version: 3 Date: 11 Nov 2023
Reviewer's report:
1. In the abstract,  The conclusion should be revised. This article not just discussed  the recurrence
of HCC, but also the HCC incidence.
2. The introduction should be concise and clear.
3. Figure 5-7 should be merged into 1 figure.
4. And due to the limited data, the conclusion should made carefully.
assistant